The Client

A US-based biopharmaceutical company with a market-leading portfolio in a chronic disease area launching a new asset into the space


To build a global and affiliate forecast model that aligned to brand strategy and allowed for differing scenarios to inform future revenue performance in an uncertain regulatory environment


  • Working with the global cross-functional team and their internal launch process, we developed a launch strategy and plan through several internal engagements/workshops
  • With our deep understanding of the market and brand strategy, we developed an epidemiology-driven Excel®-based forecast model that reflected the market structure and patient journey for the asset and that also met financial reporting requirements while having flexibility to account for differing regulatory outcomes
  • The global model architecture was streamlined and guidance documents were developed for affiliate level ‘bottom up’ forecast needs

Valued Outcome

Understanding the patient journey
Forecast model alignment to the patient journey aided senior management understanding of brand strategy toward revenue expectations
Adapting to evolving regulatory scenarios
The client can now quickly assess evolving regulatory scenarios to see the impact of strategy and forecast, helping to inform internal global governance meetings on the best path forward
Linking forecast and strategy
There is now a coherent and consistent view of the relationship between forecast and strategy throughout the organization